Amelioration for allergic rhinitis and asthma. The treated yeast milmed and physical exercise

In the developed, industrial world, about 20% of people are affected by allergic rhinitis, about 6% of people have at least one food allergy, and about 20% have atopic dermatitis at some point in time. The global prevalence of allergies and asthma has increased, quite exponentially, during the last decades with WHO estimating above 400 million individuals debilitated by allergic rhinitis and 300 million by asthma; furthermore, 25-32% of European populations remain affected [1,2]. The postulated links between these conditions [3] demand a mandatory integration between to optimize treatment effects [2,4]. In some countries, up to 18% of people have asthma. Rates of many allergic diseases appear to be increasing. More than 150 million Europeans suffer from chronic allergic diseases and the current prediction is that by 2025 half of the entire EU population will be affected (EAACI, 2016).